Research peptide
CJC-1295 9 (no Dac)
10mg
Select size
$48.50CAD
Volume pricing
- Buy 2Save 5%$92.15 ($46.08 each)
- Buy 3Save 10%$130.95 ($43.65 each)
Applies to the total quantity in your cart.
Research material
Supplied in a sealed glass vial and labelled with a batch reference. Batch-specific documentation is available on request. For Research Use Only. Not for Human or Animal Use.
- Presentation
- 10mg
- Container
- Sealed glass vial
- Batch reference
- Printed on every unit
- Documentation
- Batch-specific COA on request
- Research use
- For Research Use Only
Description
CJC-1295 (No DAC) is a synthetic analogue of growth hormone-releasing hormone (GHRH) designed to investigate the regulation of the endogenous growth hormone (GH) axis. Unlike the DAC-modified form, CJC-1295 (No DAC) has no Drug Affinity Complex, resulting in a shorter duration of systemic exposure and a research profile more closely associated with transient GHRH-receptor signaling.
CJC-1295 (No DAC) acts through the GHRH receptor (GHRHR) in the pituitary, providing a model for studying the signaling pathways involved in endogenous GH secretion. Research interest includes the interaction between GHRH signaling, pulsatile GH release, and downstream IGF-1 activity.
The shorter-acting profile makes CJC-1295 (No DAC) particularly relevant to research examining pulsatile endocrine signaling, rather than the prolonged exposure associated with CJC-1295 (DAC). It is therefore frequently investigated alongside other GH-axis research compounds, including selective growth-hormone secretagogues such as ipamorelin.
Key Research Areas
- GHRH receptor signaling
- Growth hormone secretion and pulsatilty
- GH / IGF-1 axis research
- Pituitary endocrine physiology
- Growth hormone secretagogue interactions
- Metabolic and body-composition research
- Sleep-related endocrine pathways
- Recovery and exercise physiology
At Kinetus Biolabs, CJC-1295 (No DAC) is positioned as an investigational short-acting GHRH analogue for researchers studying endogenous GH regulation, GHRH-receptor signaling, and the physiological pathways connecting GH and IGF-1 activity.
Kinetus Biolabs | Precision Science. Peak Potential.
Research Use Only — Not for Human Consumption.
